Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Choong NW, Mauer AM, Haraf DJ, Lester E, Hoffman PC, Kozloff M, Lin S, Dancey JE, Szeto L, Grushko T, Olopade OI, Salgia R, Vokes EE.
Choong NW, et al. Among authors: hoffman pc.
J Thorac Oncol. 2008 Sep;3(9):1003-11. doi: 10.1097/JTO.0b013e31818396a4.
J Thorac Oncol. 2008.
PMID: 18758303
Free PMC article.
Clinical Trial.